VC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| [Retracted] Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas | Neuro-oncology |  | 2012 | 705 | 0 | ||
| In vivo metabolic profiling of glioma-initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla | NMR in biomedicine |  | 2012 | 621 | 0 | ||
| [Retracted] Marker-independent identification of glioma-initiating cells | Nature methods | | 2010 | 543 | 0 | ||
| Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells | The Journal of biological chemistry | | 2010 | 710 | 1 | ||
| Limits of CD133 as a marker of glioma self-renewing cells | International journal of cancer | | 2009 | 645 | 0 | ||
| Identification of cancer stem cells in Ewing's sarcoma | Cancer research | | 2009 | 590 | 0 | ||
| EZH2 is essential for glioblastoma cancer stem cell maintenance | Cancer research | | 2009 | 650 | 0 | ||
| HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity | Current biology |  | 2007 | 668 | 655 | ||
| Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways | Proceedings of the National Academy of Sciences of the United States of America | | 2007 | 542 | 0 | ||
| Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer | Cancer research | | 2005 | 600 | 0 |
